Enrique V. Carbajal, MD; Grace W. Huang, DO; Billy Hu, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Carbajal E., Huang G., Hu B.; Cardiac Resynchronization Therapy in Heart Failure. Ann Intern Med. 2005;142:305. doi: 10.7326/0003-4819-142-4-200502150-00016
Download citation file:
Published: Ann Intern Med. 2005;142(4):305.
TO THE EDITOR:
McAlister and colleagues (1), in their systematic review, concluded that cardiac resynchronization therapy (CRT) reduces all-cause mortality and heart failure hospitalizations when added to medical therapy in selected patients with heart failure. Among some U.S. cardiologists, there appears to be a perception that patients with heart failure should receive a device with defibrillator ability and biventricular pacing function. It is likely that the report by McAlister and colleagues will further contribute to this perception and possibly influence practice trends.
McAlister and colleagues used a comprehensive search strategy and intensive extraction and evaluation of data from pertinent studies. However, their analysis could not overcome certain methodologic deficiencies (for example, concealed randomization, lack of blinding or partial blinding, and intention-to-treat analyses) that affected several of the studies. Such deficiencies can lead to preferential management or treatment, resulting in better or improved outcomes that favor the intervention of interest (in this case, CRT). In addition, the crossover design of several studies further restricted the already limited data available for evaluation of mortality rates and hospitalizations.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only